GuarionexJoelDeCastroMD

Surgical Oncology

Associate Professor Department of Urology Columbia University Irving Medical Center/NY Presbyterian Hospital

Overview of Dr. DeCastro

Dr. G. Joel DeCastro is a urologist in New York, NY and is affiliated with New York Presbyterian/Columbia University Irving Medical Center.

He received his medical degree from Columbia University and has been in practice 13 years. He specializes in urologic oncology and is experienced in prostate, bladder, and kidney cancer, focusing on laparoscopic and robotic techniques.

Office
161 Fort Washington Ave
Fl 11
New York, NY 10032
Book by Phone+1(651) 314-1539

Fax+1 212-305-0116

Education & Training

University of ChicagoFellowship, Urologic Surgical Oncology, 2009 - 2011
New York Presbyterian Hospital (Columbia Campus)Residency, Urology, 2005 - 2009
New York Presbyterian HospitalInternship, Transitional Year, 2004 - 2005
Columbia University Vagelos College of Physicians and SurgeonsClass of 2004
Harvard UniversityBS, Biology, Cum Laude, 1993 - 1997

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2006 - 2026
CT State Medical License 2014 - 2015
IL State Medical License 2009 - 2011
American Board of Urology Urology

Clinical Trials

Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder Start of enrollment: 2014 Dec 01
Active, not recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

Neoadjuvant androgen deprivation therapy with or without Fc-enhanced non-fucosylated anti-CTLA-4 (BMS-986218) in high risk localized prostate cancer: a randomized phas...
Casey R Ager, Aleksandar Obradovic, Patrick McCann, Matthew Chaimowitz, Alexander L E Wang
Medrxiv. 2024-09-11
7 citations
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.
Jessica E Hawley, Aleksandar Z Obradovic, Matthew C Dallos, Emerson A Lim, Karie Runcie
Cancer Cell. 2023-11-13
7 citations
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.
Prabhjot S Mundi, Filemon S Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen
Cancer Discovery. 2023-06-02

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment